What does the evidence say about Synbiotic Constipation Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Synbiotic Constipation Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Synbiotic supplementation significantly reduced levels of key muscle injury markers (CK, p < 0.001; AST, p = 0.01) and inflammatory markers (TNF-α, p < 0.001; hs-CRP, p < 0.001) compared to placebo. [Bideshki MV (2026); evidence level 2] - It also significantly improved body composition by reducing fat mass and body fat percentage (both p = 0.01). [Bideshki MV (2026); evidence level 2] - Professional futsal players experience significant muscle injury, inflammation, and body composition alterations due to intense training. [Bideshki MV (2026); evidence level 2] - This 12-week double-blind, randomized clinical trial investigated the efficacy of synbiotic supplementation in 25 players assigned to either a synbiotic group (n = 13) receiving 10⁹ CFU of seven probiotic strains plus 375 mg fructooligosaccharides, or a placebo group (n = 12). [Bideshki MV (2026); evidence level 2] - Probiotics can alleviate some gastrointestinal (GI) symptoms; however, evidence for their impact on bloating, gas and abdominal discomfort in otherwise healthy populations remains limited. [Allegretti JR (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.